MBX Biosciences, Inc. (MBX)
53.31
-1.23
(-2.26%)
USD |
NASDAQ |
Oct 08, 16:00
53.31
0.00 (0.00%)
After-Hours: 16:49
MBX Biosciences Price : 53.31 for Oct. 8, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 07, 2026 | 56.38 | 58.50 | 53.36 | 54.54 | 357159.0 |
| Oct 06, 2026 | 58.75 | 59.22 | 55.34 | 56.92 | 366626.0 |
| Oct 05, 2026 | 58.33 | 59.26 | 56.42 | 58.54 | 583214.0 |
| Oct 02, 2026 | 59.28 | 61.12 | 56.90 | 58.51 | 637323.0 |
| Oct 01, 2026 | 58.47 | 60.20 | 56.15 | 56.55 | 434149.0 |
| Sep 30, 2026 | 58.19 | 59.40 | 56.10 | 58.62 | 523793.0 |
| Sep 29, 2026 | 57.27 | 58.24 | 56.55 | 57.75 | 357124.0 |
| Sep 28, 2026 | 52.86 | 58.49 | 52.59 | 57.54 | 439613.0 |
| Sep 25, 2026 | 55.83 | 56.00 | 52.32 | 53.63 | 563530.0 |
| Sep 24, 2026 | 57.56 | 57.72 | 54.41 | 55.39 | 638966.0 |
| Sep 23, 2026 | 61.85 | 61.85 | 57.82 | 57.89 | 352410.0 |
| Sep 22, 2026 | 61.14 | 63.45 | 60.84 | 61.98 | 433368.0 |
| Sep 21, 2026 | 63.46 | 64.61 | 59.97 | 60.94 | 903395.0 |
| Sep 18, 2026 | 64.00 | 64.04 | 61.40 | 62.91 | 932362.0 |
| Sep 17, 2026 | 62.50 | 65.00 | 62.50 | 63.89 | 969814.0 |
| Sep 16, 2026 | 61.34 | 62.75 | 59.49 | 61.57 | 1.160M |
| Sep 15, 2026 | 58.79 | 61.20 | 58.39 | 61.08 | 652593.0 |
| Sep 14, 2026 | 59.35 | 60.22 | 58.87 | 59.49 | 323679.0 |
| Sep 11, 2026 | 61.75 | 61.94 | 58.42 | 59.02 | 306208.0 |
| Sep 10, 2026 | 62.43 | 63.02 | 60.65 | 60.94 | 457267.0 |
| Sep 09, 2026 | 63.29 | 64.04 | 61.28 | 62.91 | 315690.0 |
| Sep 08, 2026 | 60.85 | 64.17 | 60.66 | 62.99 | 266221.0 |
| Sep 04, 2026 | 61.00 | 62.73 | 60.60 | 61.72 | 271775.0 |
| Sep 03, 2026 | 60.90 | 62.61 | 59.84 | 61.42 | 292658.0 |
| Sep 02, 2026 | 61.40 | 62.45 | 58.80 | 60.89 | 352286.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amylyx Pharmaceuticals, Inc. | 27.19 |
| ANI Pharmaceuticals, Inc. | 71.95 |
| Corcept Therapeutics, Inc. | 118.54 |
| Veru, Inc. | 2.41 |
| Johnson & Johnson | 256.43 |
Price Related Metrics
| PEG Ratio | -5.041 |
| Price to Book Value | 6.242 |
| Earnings Yield | -4.51% |
| Market Cap | 2.556B |
| PEGY Ratio | -5.041 |